BUGS&DRUGS

BUGS&DRUGS By www.FreePharmacyJobs.com

Following the Pharmacy market and the products and services which drive it forward.

Web

Images

BUGS&DRUGS >> PHARMACEUTICAL INDUSTRY

November 26, 2009

members login here

Focus Channels

  Biological sciences
  Biotech
  Cancer
  Genetics
  Healthcare
  Medical
  Pharmaceutical Industry
  Public health

Participate

Build a News Circle

Receive News Briefings

Add this Circle to favorites

Share this News Circle

Subscribe to this News Circle

Useful Links

Pharmacy Jobs

>>	PHARMACEUTICAL INDUSTRY

MidSouth Bancorp to raise $30 million through secondary offering ...

Zibb - 5 Hours ago

Company: Midsouth Bancorp, Inc. (MSL) MidSouth Bancorp, Inc., a US-based bank holding company, is planning to raise approximately $30 million through a public offering of shares of its common stock. MidSouth

Jazz Pharmaceuticals raises $120 million through private placemen... Zibb

Salinas Energy raises $5.27 million through private placement - Z... Zibb

all 12 news articles >> Add Comment

Ranbaxy launches generic version of Valtrex in US

Livemint.com - 4 Hours ago

New Delhi: In what could be a huge relief for Indiaâ??s largest drug maker, Ranbaxy Laboratories Ltd has launched its generic version of GlaxoSmithKline Plcâ??s (GSK) herpes drug Valtrex in the US in

Ranbaxy set for Rs 1000 cr boost from Valtrex clone DNA India

Ranbaxy takes on GSK's Valtrex in US Times of India

all 2 news articles >> Add Comment

S. Korea unlikely to buy problematic H1N1 vaccine from GSK - Zibb...

Zibb - 9 Hours ago

Company: GlaxoSmithKline plc (GSK) South Korea will likely not order a vaccine against the Influenza A (H1N1) virus made by GlaxoSmithKline Plc. (GSK) after the product seemed to have caused a series

S. Korea unlikely to buy problematic H1N1 vaccine from GSK TradingMarkets

all 1 news articles >> Add Comment

ALDA Pharma Inks Deal With Shoppers Drug Mart - Quick Facts

RTTNews.com - 10 Hours ago

Pharma Inks Deal With Shoppers Drug Mart - Optional: Temporarily hide the 'tabber' class so it does not 'flash' on the page as plain HTML. After tabber runs, the class is changed to 'tabberlive' and it

ALDA Enters into Agreement with Shoppers Drug Mart Individual.com

all 1 news articles >> Add Comment

Oceanside Pharmaceuticals launches generic Librax - Zibb.com

Zibb - 13 Hours ago

Company: Valeant Pharmaceuticals International (VRX) Oceanside Pharmaceuticals, part of Valeant Pharmaceuticals International, has launched chlordiazepoxide hydrochloride and clidinium bromide, an authorized

Add Comment

Nymox Pharmaceutical reports positive data from Phase II BPH stud...

Zibb - 13 Hours ago

Company: Nymox Pharmaceutical Corp. (NYMX) Nymox Pharmaceutical has reported new positive clinical trial data from responder analysis of the company's pooled multi-center US Phase II studies of NX-1207,

Nymox Pharmaceutical reports positive data from Phase II BPH studies TradingMarkets

terna Zentaris gets positive data from phase-2 study of targeted cytotoxic peptide PharmaBiz

all 2 news articles >> Add Comment

Biosante Pharmaceuticals Down 4.8% Since SmarTrend's Sell Recomme...

Zibb - 20 Hours ago

Company: BioSante Pharmaceuticals, Inc. (BPAX) SmarTrend, our proprietary pattern recognition system, called a Downtrend for Biosante Pharmaceuticals (NASDAQ:BPAX) on October 28, 2009 at $1.56. Since

Biosante Pharmaceuticals Down 4.8% Since SmarTrend's Sell Recommendation TMC Net

Cadence Pharmaceuticals Down 12.5% Since SmarTrend's Sell Recomme... Zibb

all 10 news articles >> Add Comment

ISTA Pharmaceuticals, Inc. (ISTA) Corporate Event Announcement No...

Zibb - 21 Hours ago

ISTA Pharmaceuticals, Inc. (ISTA) Expected next earnings release: Announcement date: 2/18/2010 - After Market Earnings Quarter: Q4 Announcement Status: Unconfirmed Expected next investor conference call

Add Comment

Roche seeks broader EU breast cancer label for drug

Reuters Health - 23 Hours ago

* EU approval sought for broader Avastin breast cancer use * Application based on study on benefits with chemotherapy ZURICH (Reuters) - Swiss drugmakerRoche Holding has filed for European approval to

Avastin Filed For Broader Breast Cancer Label In Europe For Use In Combination With Pharma Live

UPDATE 1-Roche seeks broader EU breast cancer label for drug Reuters UK

all 2 news articles >> Add Comment

(Tentative) Q3 2008 VIOQUEST PHARMACEUTICALS INC Earnings Release - ESTIMATED

Reuters - 11/26/2009

VioQuest Pharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of clinical stage drug therapies targeting both the molecular basis of cancer

(Tentative) Q3 2009 MDI, Inc. Earnings Release - ESTIMATED Reuters

all 1 news articles >> Add Comment

Heska signs supply agreement with Roche Diagnostics

TradingMarkets - 5 Hours ago

- Heska Corporation has signed an agreement with Roche Diagnostics Corp., a division of F. Hoffmann-La Roche, Ltd., for the supply of blood gas products and affiliated consumables for the veterinary market.

Heska signs supply agreement with Roche Diagnostics - Zibb.com Zibb

Heska Announces Supply Agreement With Roche Diagnostics MedIndia

all 4 news articles >> Add Comment

Novartis Shells Out $210M for Two of Incyteâ??s Hematology-Oncology Candidates

Genetic Engineering News - 83 Minutes ago

Novartisis paying Incyte Pharmaceuticals $150 million up front and an additional $60 million immediate milestone payment as part of an exclusive licensing deal for two of the latterâ??s clinical-stage

Add Comment

Research shows how anti-cancer drug works

UPI - 5 Hours ago

Researchers at Illinois' Northwestern University said they discovered how the drug tetrathiomolybdate, which is used to fight some metastatic cancers, works. Northwestern said in a release Thursday while

Researchers Optimistic Over New Cancer Pain Drug Pharmaceutical Technology

all 1 news articles >> Add Comment

Jubilant partners with US researchers on drug development

Outsourcing Pharma - 6 Hours ago

Indian CRAMS firm Jubilant Organosys has teamed up with the University of Alabama (UAB) and the Southern Research Institute (SRI) to develop affordable treatments for cancer, infection and metabolic disorders.

Add Comment

Ablynx awarded 1.1 M grant; reaches milestone in Novartis collaboration

Science Business - 7 Hours ago

een awarded aworth 1.1 million by the Flemish agency for Innovation by and Technology (IWT). The money will allow the company to accelerate development of alternative routes of administration for its

Add Comment

Merck Serono to invest 150 M in Chinese R&D centre

Science Business - 7 Hours ago

Serono has announced it is to establish a global R&D centre in Beijing,, investing more than 150 million and creating 200 new jobs over the next four years. The centre will specialise in biomarkers, pharmacogenomics

Add Comment

Pooled analysis of rofecoxib placebo-controlled clinical trial data: lessons for

Bioscience Technology Online - 9 Hours ago

Biological or potency assays are frequently analyzed with the help of the parallel-line or parallel-logistic (4 or 5 parameter fit) methods. These methods have major advantages over traditional single-point

Add Comment

Pharmaceuticals and society: critical discourses and debates (book review)

PJ Online - 9 Hours ago

Science and politics â??Pharmaceuticals and society: critical discourses and debatesâ??, by Simon J. Williams, Jonathan Gabe and Peter Davis. Pp viii+160. Price Â£19.99. Chichester: Wiley-Blackwell; 2009.

Add Comment

S Korea may scrap plan to buy Influenza A vaccine from GSK

People's Daily Online - 9 Hours ago

Increases the bookmark twitter facebook digg Google Windowslive Delicious buzz friendfeed Linkedin diigo reddit stumbleupon The South Korean government may not go on with its plan to purchase a vaccine

Add Comment

FDA Approves Treatment for Resistant HIV Patients

Pharmaceutical Technology - 13 Hours ago

The US Food and Drug Administration (FDA) has granted approval for Intelence, a treatment specifically indicated for treatment-experienced patients who have experienced virologic failure from antiviral-resistant

FDA grants full approval to J&J's HIV drug Rocky Mount Telegram

Intelence Receives Full FDA Approval AIDSmeds

all 2 news articles >> Add Comment

Gilead and GSK Enter Asian Hepatitis Market

Pharmaceutical Technology - 14 Hours ago

Gilead Sciences and GlaxoSmithKline have announced a licensing agreement to commercialise Viread to treat chronic hepatitis B (HBV) infection in adults in five Asian countries. Under the agreement, Gilead

GSK and Gilead Sciences sign licensing agreement - Zibb.com Zibb

GSK, Gilead enter licensing pact to commercialise HB V drug Viread in 5 Asian countries PharmaBiz

all 4 news articles >> Add Comment

Asterand extends collaboration with Bristol-Myers

TradingMarkets - 14 Hours ago

Look up the PowerRating of BMY and see how it has performed over the past week as well as the current proprietary PowerRating. Nov 26, 2009 (Datamonitor via COMTEX) -- BMY | Quote | Chart | News | PowerRating

Add Comment

Spectrum Pharmaceuticals and Handok sign collaboration agreement

TradingMarkets - 14 Hours ago

Set_Cookie( 'test', 'none', '', '/', '', '' (Get_Cookie( 'test')) else //BEGIN EDITABLE SECTION //CONFIGURATION VARIABLES NUMBER(S) NAME(S) CONTENT CATEGORY PAGE NAME CONTENT CATEGORY //OPTIONAL PAGE

Spectrum collaborates with Handok to develop & commercialize apaziquone in S Korea PharmaBiz

all 1 news articles >> Add Comment

FreightCar America Down 13.3% Since SmarTrend's Sell Recommendation

TMC Net - 16 Hours ago

13.3% Since SmarTrend's Sell Recommendation TMC Launches New Sites :: EXPO Magazine UC Magazine NGN Magazine nology EXPO Show Daily Evolution Conference Summit Evolution Digium World Conference VoIP Forum

Books-A-Million Down 31.9% Since SmarTrend's Sell Recommendation TMC Net

Array Biopharma Down 32.4% Since SmarTrend's Sell Recommendation TMC Net

all 112 news articles >> Add Comment

Novartis opens first large-scale cell-culture influenza vaccine manufacturing facility

PharmaBiz - 17 Hours ago

Novartis officially inaugurated the US's first ever large-scale flu cell culture vaccine and adjuvant manufacturing facility in Holly Springs, North Carolina. The facility is a result of a partnership

Add Comment



	Already a member? Sign in


	Email Address:
	Password:


Forget your password?

Build a News Circle | Get News Briefings | Congoo News Home | Get the Netpass

About Congoo | Terms of Use | Privacy Policy | Need Help? | Site Map